NasdaqGS - Delayed Quote USD
Metsera, Inc. (MTSR)
28.12
+1.40
+(5.24%)
At close: 4:00:01 PM EDT
28.12
0.00
(0.00%)
After hours: 4:04:03 PM EDT
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| ARCH VENTURE PARTNERS XII, LLC Beneficial Owner of more than 10% of a Class of Security | Purchase | Feb 3, 2025 | -- |
| BERNS PAUL L Director | Purchase | Feb 3, 2025 | -- |
| BUROW KRISTINA M Director and Beneficial Owner of more than 10% of a Class of Security | Purchase | Feb 3, 2025 | -- |
| FMR LLC Beneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security | Feb 3, 2025 | -- |
| WELLINGTON BIOMEDICAL INNOVATION MASTER INVESTORS CAYMAN II Beneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security | Jan 30, 2025 | 1,857,700 |
Related Tickers
MAZE Maze Therapeutics, Inc.
12.10
+20.88%
GPCR Structure Therapeutics Inc.
21.79
+0.14%
AARD Aardvark Therapeutics, Inc.
11.13
+6.61%
SION Sionna Therapeutics, Inc.
13.97
+2.05%
CYTK Cytokinetics, Incorporated
31.21
+0.61%
IMVT Immunovant, Inc.
15.41
+3.77%
APGE Apogee Therapeutics, Inc.
36.33
-0.85%
LXEO Lexeo Therapeutics, Inc.
2.7200
0.00%
ASND Ascendis Pharma A/S
175.69
+7.89%
SRRK Scholar Rock Holding Corporation
29.76
+2.59%